As shown in Figure 5, the set of proteins was significantly enriched in nine pathways between the MP and LP treatments: Huntington's disease, the NOD-like receptor signaling pathway, salivary secretion, the calcium signaling pathway, fatty acid biosynthesis, porphyrin and chlorophyll metabolism, IL-17 signaling pathway, olfactory transduction, and aminoacyl-tRNA biosynthesis. The gene discussed is IL17A; the disease is juvenile Huntington disease.